84 HR oxybutynin 0.162 MG/HR Transdermal System
RxNorm concept 403799, clinical drug (scd). Prescribable name: oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal System.
- RxCUI
- 403799
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/403799 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
84 HR oxyBUTYnin 0.162 MG/HR Transdermal System; oxyBUTYnin 0.162 MG/HR 84 HR Transdermal Patch; oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal Patch; oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal System; oxybutynin 0.162 MG/HR 84 HR Transdermal Patch; oxybutynin 3.9 MG/Day Twice Weekly Transdermal Patch; oxybutynin 3.9 MG/Day Twice Weekly Transdermal System
Related concepts
- oxybutynin 0.162 MG/HR (SCDC, consists of)
- Transdermal System (DF, has dose form)
- 84 HR oxybutynin 0.162 MG/HR Transdermal System [Oxytrol] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 403799 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/403799 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 403799. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.